ES2059305T3 - Proteina del virus de la seudorrabia. - Google Patents

Proteina del virus de la seudorrabia.

Info

Publication number
ES2059305T3
ES2059305T3 ES86307705T ES86307705T ES2059305T3 ES 2059305 T3 ES2059305 T3 ES 2059305T3 ES 86307705 T ES86307705 T ES 86307705T ES 86307705 T ES86307705 T ES 86307705T ES 2059305 T3 ES2059305 T3 ES 2059305T3
Authority
ES
Spain
Prior art keywords
seudorrabia
virus
protein
rabicos
polipeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86307705T
Other languages
English (en)
Other versions
ES2059305T5 (es
Inventor
Erik A Petrovskis
Leonard E Post
James G Timmins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27505761&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2059305(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ES2059305T3 publication Critical patent/ES2059305T3/es
Application granted granted Critical
Publication of ES2059305T5 publication Critical patent/ES2059305T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)

Abstract

COMPRENDE UNA SECUENCIA QUE CODIFICA GLUCOPROTEINA DE VIRUS PSEUDO RABICOS SELECCIONADA ENTRE EL GRUPO DE GL, GP50, Y GP63, CELULAS ANFITRIONAS TRANSFORMADAS POR SECUENCIAS DE MOLECULA DE DNA RECOMBINADAS, LOS POLIPEPTIDOS GL, GP50 Y GP63; COMPRENDE TAMBIEN VACUNAS CONTRA LA INFECCION POR PRV Y PARA DISTINGUIR ENTRE ANIMALES VACUNADOS E INFECTADOS.
ES86307705T 1985-10-04 1986-10-06 Proteina del virus de la seudorrabia. Expired - Lifetime ES2059305T5 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US78478785A 1985-10-04 1985-10-04
US80179985A 1985-11-26 1985-11-26
US84411386A 1986-03-26 1986-03-26
US88626086A 1986-07-16 1986-07-16

Publications (2)

Publication Number Publication Date
ES2059305T3 true ES2059305T3 (es) 1994-11-16
ES2059305T5 ES2059305T5 (es) 2000-11-01

Family

ID=27505761

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86307705T Expired - Lifetime ES2059305T5 (es) 1985-10-04 1986-10-06 Proteina del virus de la seudorrabia.

Country Status (10)

Country Link
EP (2) EP0238618A1 (es)
JP (2) JP2568384B2 (es)
KR (1) KR880700074A (es)
AU (1) AU601378B2 (es)
CA (1) CA1340848C (es)
DE (1) DE3689144T3 (es)
DK (2) DK175072B1 (es)
ES (1) ES2059305T5 (es)
GR (1) GR3034271T3 (es)
WO (1) WO1987002058A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0261940A3 (en) * 1986-09-23 1989-07-05 Applied Biotechnology, Inc. Pseudorabies vaccines and dna vectors for recombination with pox viruses
US5242829A (en) * 1986-09-23 1993-09-07 Therion Biologics Corporation Recombinant pseudorabies virus
WO1988007080A2 (en) * 1987-03-09 1988-09-22 The Upjohn Company Transgenic animal cells resistant to viral infection
US5069901A (en) * 1988-02-03 1991-12-03 Jones Elaine V Preparation of a recombinant subunit vaccine against pseudorabies infection
FR2693472B1 (fr) * 1992-06-26 1994-12-23 Rhone Merieux Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation.
NL8902414A (nl) * 1989-09-28 1991-04-16 Stichting Centr Diergeneeskund Oligopeptiden/expressieprodukten van het aujeszky's disease virus en daarvoor coderende recombinante polynucleotiden.
WO1993001833A1 (en) * 1991-07-17 1993-02-04 Commonwealth Scientific And Industrial Research Organisation Improved vaccine
US20020193729A1 (en) 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2559384B2 (ja) * 1985-07-29 1996-12-04 ジ・アップジョン・カンパニ− ウイルスワクチン

Also Published As

Publication number Publication date
GR3034271T3 (en) 2000-12-29
DK288887D0 (da) 1987-06-04
JP2638588B2 (ja) 1997-08-06
EP0223382B1 (en) 1993-10-06
DE3689144T3 (de) 2001-05-17
DK175072B1 (da) 2004-05-24
AU6375186A (en) 1987-04-24
EP0223382A1 (en) 1987-05-27
DE3689144D1 (de) 1993-11-11
CA1340848C (en) 1999-12-14
EP0223382B2 (en) 2000-06-21
DE3689144T2 (de) 1994-03-03
WO1987002058A1 (en) 1987-04-09
JPH07107982A (ja) 1995-04-25
JP2568384B2 (ja) 1997-01-08
DK288887A (da) 1987-06-04
AU601378B2 (en) 1990-09-13
EP0238618A1 (en) 1987-09-30
DK35794A (da) 1994-03-29
KR880700074A (ko) 1988-02-15
JPH08334512A (ja) 1996-12-17
ES2059305T5 (es) 2000-11-01

Similar Documents

Publication Publication Date Title
EE9900343A (et) Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon
BR8905851A (pt) Processo para a deteccao de uma infeccao por aids em seres humanos;composicao de proteina de involucro do virus de aids;e kit de teste utilizavel na administracao intradermica para deteccao de uma infeccao por aids
BR9610262A (pt) Compostos e métodos para a imunoterapia e diagnose de tuberculose
ES2164883T3 (es) Compuestos y metodos para la diagnosis de la leishmaniasis.
CY1108147T1 (el) Εμβολιο κατα των σεξουαλικως μεταδιδομενων νοσων
AR042378A2 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de dicho poxvirus para preparar una vacuna eficaz contra la infeccion del virus de inmunodeficiencia felina
ES8505819A1 (es) Un procedimiento de una vacuna capaz de inducir la produccion de anticuerpos de reaccion con mas de una cepa de virus dela influenza.
CY1106635T1 (el) Ανοσοενισχυτικο που περιεχει ν - φορμυλο μεθειονυλο-πεπτιδια για εμβολια
MX9306841A (es) Vacuna a base de ureasa contra la infeccion por helicobacter en mamiferos.
NO20075900L (no) Forbindelser for immunterapi og diagnose av tuberkulose og metoder for deres anvendelse
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
ES2091777T3 (es) Procedimiento para preparar un ensayo inmunologico de transferencia western.
MX9401225A (es) Composicion de vacuna para prevenir la infeccion con influenza en humanos y metodo para su preparacion.
ES2042828T3 (es) Procedimiento de preparacion de vacunas contra tumores modificadas por virus para la inmunoterapia de metastasis de tumores.
ES2134197T3 (es) Vacunas contra el virus del herpes simplex vp16.
ES533111A0 (es) Un metodo de preparar una vacuna viva
ES2059305T3 (es) Proteina del virus de la seudorrabia.
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
ES498752A0 (es) Un procedimiento para preparar una vacuna de virus vivos de la peritonitis infecciosa de los felinos
DE69634820D1 (de) Impfstoff gegen mehrere fiv-subtypen
PL206218A1 (pl) Sposob wytwarzania oslabionego zaczepu wirusa zakaznego zapalenia zoladka i jelit oraz sposob wytwarzania szczepionki
ES519551A0 (es) Nuevas vacunas contra la bronquitis infecciosa.
ES2054256T3 (es) Fragmentos de peptido de hiv.
ES2063897T3 (es) Vacuna contra el virus del colera porcino y diagnostico.
ES2058100T3 (es) Vacuna combinada.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 223382

Country of ref document: ES